secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-10-19T23:59:59+00:00
Accession:  0000313143-22-000056
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics appoints Maryanne Farris as VP, Chief Accounting Officer; GC Michelle Basil continues
--------------------------------------------------------------------------------

- Maryanne Farris joined as VP, Chief Accounting Officer and principal accounting officer on Oct 17, 2022.
- James D'Arecca remains EVP, CFO and principal financial officer; no change in his role.
- Company and EVP/GC Michelle Basil mutually agreed to terminate a June 2022 transition letter; she continues in her current role.
- Ms. Farris previously served as Chief Accountant at Azenta, Inc. and is a CPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000056/0000313143-22-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000056/hae-20221014.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer